Idarucizumab safe for reversal of dabigatran-induced anticoagulation

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2015年 / 1558卷 / 1期
关键词：
D O I：
10.1007/s40278-015-2998-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 9
相关论文
共 50 条
  • [21] Dabigatran-induced esophagitis
    Kajihara, Yusaku
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2019, 86 (05) : 303 - 304
  • [22] Dabigatran-Induced Nephropathy and Gastrointestinal Bleeding and Its Successful Treatment with Idarucizumab: A Case Report
    Marchesini, Francesca
    Ossato, Andrea
    Zendrini, Alberto
    Arginelli, Federica
    Zuppini, Teresa
    Realdon, Nicola
    Zamperini, Massimo
    Tessari, Roberto
    HOSPITAL PHARMACY, 2022, 57 (02) : 241 - 245
  • [23] Refractory Dabigatran-Induced Hemorrhage Despite Multiple Idarucizumab Administration and Renal Replacement Therapy
    Flynn, Francis
    Richard, Guillaume
    Dobrescu, Marc A.
    Bouchard, Josee
    Williamson, David
    Brindamour, Dave
    Charbonney, Emmanuel
    Dupuis, Sebastien
    JOURNAL OF PHARMACY PRACTICE, 2022, 35 (02) : 302 - 307
  • [24] Evidence Supporting Idarucizumab for the Reversal of Dabigatran
    Pollack, Charles V., Jr.
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (11): : S73 - S79
  • [25] Reversal of dabigatran by idarucizumab: when and how?
    Vanassche, Thomas
    Greinacher, Andreas
    Verhamme, Peter
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (06) : 519 - 528
  • [26] Idarucizumab Approved for Anticoagulation Reversal
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (12) : 876 - 876
  • [27] Dabigatran-induced nephropathy and its successful treatment with Idarucizumab - case report and literature review
    Awesat, Jenan
    Sagy, Iftach
    Haviv, Yosef S.
    Rabinovich, Anat
    Jotkowitz, Alan
    Shleyfer, Elena
    Barski, Leonid
    THROMBOSIS RESEARCH, 2018, 169 : 120 - 122
  • [28] Idarucizumab: A Review as a Reversal Agent for Dabigatran
    Yahiya Y. Syed
    American Journal of Cardiovascular Drugs, 2016, 16 : 297 - 304
  • [29] Evidence supporting idarucizumab for the reversal of dabigatran
    Pollack, Charles V., Jr.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (11): : 33 - 38
  • [30] Idarucizumab: A Review as a Reversal Agent for Dabigatran
    Syed, Yahiya Y.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (04) : 297 - 304
12345